Scavenger receptor
AssigneeFuso Pharmaceutical Industries, Ltd.
InventorNobutaka Wakamiya
Life of this patent
Estimating the term…
Loading patent…
AssigneeFuso Pharmaceutical Industries, Ltd.
InventorNobutaka Wakamiya
Estimating the term…
Novel scavenger receptors having an SR structure and a collectin-like structure are provided, which can be utilized in the elucidation of mechanisms of macrophage and basic immunity; in the elucidation of mechanisms of the development of a wide variety of diseases such as arteriosclerosis, diabetic complications and Alzheimer's disease, hyper β-lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo α-lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections; in the diagnostic, prophylactic and therapeutic methods thereof; and in the development of reagents and drugs for the same. The novel scavenger receptors include proteins comprising an amino acid sequence set out in SEQ ID NO: 2, 4 or 24 or proteins having equivalent properties to the same, or derivatives or fragments thereof as well as isolated polynucleotides comprising a nucleotide sequence encoding these proteins, and related molecules such as antibodies, antagonists and the like. Also disclosed are methods for the treatment using the same.
A monoclonal antibody produced by a method comprising
A monoclonal antibody having specificity for a protein that has an amino acid sequence consisting of residues 1-742 of SEQ ID NO:
Dependencies are inferred from the claim text.